Has Ryan Miller received payments from drug or device companies?

Yes. Drug and device makers reported $5,191 in general payments to Ryan Miller across 46 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ryan Miller did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ryan Miller come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ryan Miller

Pediatric Endocrinology · Baltimore, MDNPI 1932262037

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $3,511 of the $5,191 with a category attached, or 67.6%. Novo Nordisk accounts for 80.2% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2023 at $4,264 and has fallen 89.1% since, to $466 in 2025.

$5,191in general payments, 2019–2025

Across 46 payments — averaging $112.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novo Nordisk$4K
Sanofi-aventis U.S. LLC$243
Insulet Corporation$125
Xeris Pharmaceuticals, Inc.$103
AbbVie$82
Kyowa Kirin, Inc.$56
plus $420 from 12 others

$116,741in research payments, 2019–2025

Across 8 payments — averaging $14,593 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Sanofi US Services Inc.$117K

What the payments were for

Consulting fees$3,51168%
Travel & lodging$2054%
Food & beverage$1,42427%
Education$501%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novo Nordisk	10	$4,161
Sanofi-aventis U.S. LLC	5	$243
Insulet Corporation	1	$125
Xeris Pharmaceuticals, Inc.	6	$103
AbbVie	3	$82
Kyowa Kirin, Inc.	2	$56
Dexcom, Inc.	2	$54
Neurocrine Biosciences, Inc.	2	$54
Tolmar Pharmaceuticals, Inc.	2	$50
Takeda Pharmaceuticals U.S.A., Inc.	2	$44
Ascendis Pharma Endocrinology Inc	2	$44
Azurity Pharmaceuticals, Inc.	2	$40
Medtronic	2	$39
Soleno Therapeutics, Inc.	1	$25
Tandem Diabetes Care, Inc.	1	$21
Pfizer	1	$19
AstraZeneca	1	$15
Calliditas Therapeutics US Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Norditropin$3,863
Omnipod$125
TZIELD$108

How this compares

$5,191 in reported general payments places this provider in the 80th percentile of 33 pediatric endocrinology providers in Maryland.

See all pediatric endocrinology providers in Maryland →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Levothyroxine Sodium	11	$56

Paid to pharmacies, not to this prescriber.

Other pediatric endocrinology in Baltimore

Barry ReinerBaltimore$15K
David CookeBaltimore$8K
Risa WolfBaltimore$7K
Sandra SalsbergBaltimore$3K
Katherine BeckwithBaltimore$871
Paula NewtonBaltimore$854
Talia HittBaltimore$350
Albara MarwaBaltimore$178
Scott BlackmanBaltimore$156
Joseph HeinemannBaltimore$147

See the full list for Maryland →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →